Form 4: Boston Scientific Executive Exercises Stock Options and Sells Shares Under 10b5-1 Plan

Arthur C. Butcher, an Executive Vice President at Boston Scientific, executed stock options and sold shares of common stock under a pre-established Rule 10b5-1 trading plan.

Summary

• Arthur C. Butcher, an EVP at Boston Scientific, reported transactions involving the company's common stock on May 28, 2024.
• Butcher exercised stock options to acquire 3,177 shares at $22.71 and 1,009 shares at $17.26.
• He then sold 14,011 shares at a weighted average price of $75.3401.
• These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.
• Following these transactions, Butcher directly owns 20,197 shares and indirectly owns 2,539 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is common for executives to have pre-established trading plans to manage their stock holdings.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a form of long-term incentive.
• Rule 10b5-1 trading plans are a common mechanism for insiders to sell shares without raising concerns about trading on non-public information.
• The details of the plan are not disclosed, so it is not possible to compare the plan to industry standards.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares by an executive.
• The impact is likely minimal as the transactions were conducted under a pre-established trading plan.

Key Dates